BACKGROUND & AIMS: We sought to identify and quantify the clinical factors that were
associated with opportunistic infections in inflammatory bowel disease patients. METHODS: We …

… Scott L MD 1, 2 ; Kammer, Patricia P CCRP 1 ; Orenstein, Robert DO 3 ; St Sauver, Jennifer L
PhD 4 ; … Kammer; study design and drafting the manuscript: Robert Orenstein; study design, …

Modern approaches to the diagnosis and management of urinary tract infections in adults
are based on risk stratification.

Background. Managing recurrent Clostridium difficile infection (CDI) presents a significant
challenge for clinicians and patients. Fecal microbiota transplantation (FMT) is a highly …

This paper summarizes prior and on-going machine evaluations of thermal barrier coatings (TBC)
for power generation, that is large industrial gas turbine applications. Rainbow testing …

Background The role of the gut microbiome in arresting pathogen colonization and growth
is important for protection against Clostridium difficile infection (CDI). Observational studies …

… Burger MD i , Robert Orenstein DO j , Hugo E. Vargas MD k , Raj Palraj MBBS a , Ala S.
Dababneh MD a , Gabrielle Chappell l , Dale Chappell MD, MBA l , Omar Ahmed PharmD l , …

Background The pathophysiology of COVID-19 includes immune-mediated
hyperinflammation, which could potentially lead to respiratory failure and death. Granulocyte-macrophage …

Background Despite advancements, recurrent Clostridium difficile infections (CDI) remain
an urgent public health threat with insufficient response rates to currently approved antibiotic …

Background Effective treatment options for recurrent Clostridioides difficile infection (rCDI)
are limited, with high recurrence rates associated with the current standard of care. Herein we …